Albemarle Corporation (ALB) Stock Price & Analysis
Albemarle Corporation (ALB) closed at USD 92.54 on Thursday, October 22, 2026, down 2.04% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 92.54; the Oct 22, 2026 session ranged USD 91–92.65 on volume of 2,253,871 shares. Market capitalization is —, with a 52-week range of USD 88.01–221 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 10:01 UTC.
Also available as compact Markdown for AI agents: nexqual.com/ALB.md
Key facts (ALB)
- Last four reported quarters (through Jun 30, 2026): revenue $5.91B, net income $224M (3.8% margin), free cash flow $1.34B (SEC filings).
- Insider open-market sales, last ~7 months: 1 Form 4 filings, $3.0M; 1 not under a Rule 10b5-1 plan ($3.0M); 0 by opportunistic insiders, 0 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Total return with dividends: 1Y -3.9% vs S&P 500 +14.9%; 5Y -57.5% vs S&P 500 +80.3%.
- Next earnings: 2026-11-04, EPS estimate USD 2.52, revenue estimate $1.52B.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (ALB)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $3.33B | $7.32B | $9.62B | $5.38B | $5.14B | $5.91B |
| Gross profit | $998M | $3.07B | $1.19B | $62.5M | $669M | — |
| Operating income | $798M | $2.47B | $252M | -$1.78B | -$367M | $252M |
| Net income | $124M | $2.69B | $1.57B | -$1.18B | -$511M | $224M |
| EPS (diluted) | $1.06 | $22.84 | $13.36 | -$11.20 | -$5.76 | — |
| Free cash flow | -$609M | $646M | -$828M | -$993M | $692M | $1.34B |
| Gross margin | 30.0% | 42.0% | 12.3% | 1.2% | 13.0% | — |
| Operating margin | 24.0% | 33.7% | 2.6% | -33.0% | -7.1% | 4.3% |
| Net margin | 3.7% | 36.7% | 16.4% | -21.9% | -9.9% | 3.8% |
| Revenue growth | +6.4% | +120.0% | +31.4% | -44.1% | -4.4% | — |
| Cash + short-term investments | $439M | $1.50B | $890M | $1.19B | $1.62B | — |
| Total debt | $2.39B | $3.22B | $4.17B | $3.52B | $3.19B | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (ALB)
P/E at fiscal year-ends: Dec 2023 10.8x.
Insider sales (SEC Form 4, open-market, last ~7 months) (ALB)
0 of 1 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-05-15 | Masters J Kent | Chairman & CEO | 16,393 | $3.0M | 15.8% | No | Too little history (no open-market trades in 2025) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Analysts (ALB)
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-22 | Citigroup | Target lowered | Buy | $175 → $125 |
| 2026-10-20 | Truist Securities | Target lowered | Buy | $225 → $185 |
| 2026-10-15 | RBC Capital | Target lowered | Outperform | $157 → $129 |
| 2026-10-14 | Mizuho | Upgrade | Neutral → Outperform | $130 |
| 2026-10-13 | Barclays | Initiated | Equal-Weight | $109 |
| 2026-10-07 | Argus Research | Target lowered | Buy | $230 → $135 |
| 2026-10-05 | UBS | Target lowered | Buy | $175 → $150 |
| 2026-10-01 | Mizuho | Target lowered | Neutral | $140 → $130 |
| 2026-08-25 | JP Morgan | Target lowered | Neutral | $160 → $140 |
| 2026-08-10 | RBC Capital | Target lowered | Outperform | $166 → $157 |
| 2026-08-10 | Scotiabank | Target lowered | Sector Outperform | $200 → $190 |
| 2026-08-10 | Morgan Stanley | Target lowered | Equal-Weight | $189 → $161 |
Total return (dividends reinvested) (ALB)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | -3.9% | -57.5% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | -3.9% | -15.7% |
| Volatility (annualized) | 55.4% | 54.3% |
| Max drawdown | -56.8% (Apr 2026→Oct 2026) | -83.2% (Nov 2022→Apr 2025) |
ALB revenue by business segment (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Energy Storage | $1.28B | 73.2% | +77.9% |
| Specialties | $423.5M | 24.3% | +20.5% |
| Total revenue | $1.74B | 100% | — |
ALB revenue by region (fiscal year ended Dec 31, 2025)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| China | $2.03B | 39.4% | +3.3% |
| Other Foreign Countries | $1.08B | 20.9% | +6.3% |
| United States | $890.5M | 17.3% | -1.3% |
| South Korea | $789.5M | 15.4% | -13.5% |
| Japan | $359.6M | 7.0% | -39.0% |
| Total revenue | $5.14B | 100% | — |
As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).
ALB suppliers, customers and competitors (named in its 10-K)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Supplier | Chile | “(f) Ownership will revert to the Chilean government once we have sold all remaining amounts under our contract with the Chilean government pursuant to which we obtain lithium brine in Chile.” |
| Partner | Greenbushes | “Ltd., a company incorporated in Australia ("Talison") that owns the Greenbushes mine, and from our 50%-owned unincorporated joint venture, MARBL Lithium Joint Venture ("MARBL") in Western Australia, which owns the Wodgina hard rock lithium mine project ("Wodgina"); and (b) through solar evaporation of our ponds at the Salar de Atacama, in Chile, and in Silver Peak, Nevada.” |
| Partner | Mineral Resources | “(c) Production amounts presented from Wodgina represent 60% of production of the Wodgina mine which is attributable to the Company's interest in the MARBL joint venture until October 18, 2023, when we reduced our ownership percentage to 50% following the restructuring of the MARBL joint venture with MRL.” |
| Partner | Eurecat | “In 2025, we entered into definitive agreements to divest our 50% ownership interest in Eurecat S.A., a joint venture within the Refining Solutions reporting unit, and to divest the controlling ownership interest in our remaining Refining Solutions business.” |
| Partner | Jordan Bromine Company | “In addition, there have been concerns regarding water scarcity, declining precipitation and drought in Jordan, where our joint venture, JBC, produces bromine.” |
| Competitor | Rio Tinto (RIO) | “Major competitors in lithium compounds include Sociedad Quimica y Minera de Chile S.A., Sichuan Tianqi Lithium, Jiangxi Ganfeng Lithium, Rio Tinto plc, Pilbara Minerals, Tesla and a large number of additional Chinese companies.” |
| Competitor | Tesla (TSLA) | “Major competitors in lithium compounds include Sociedad Quimica y Minera de Chile S.A., Sichuan Tianqi Lithium, Jiangxi Ganfeng Lithium, Rio Tinto plc, Pilbara Minerals, Tesla and a large number of additional Chinese companies.” |
Quoted from the company's 10-K filed Feb 11, 2026.
Companies that name ALB in their SEC reports
| Relationship to ALB | Company | Filing | Sentence |
|---|---|---|---|
| partner | CHEMICAL & MINING CO OF CHILE INC (SQM) | 20-F Apr 22, 2026 | “SQM and Albemarle have a lease agreement with Corfo to extract and produce lithium from brines stored in the Salar de Atacama deposit.” |
| partner | ICL Group Ltd. (ICL) | 20-F Mar 11, 2026 | “Albemarle also has a joint venture with a Jordanian” |
| partner | SIGA TECHNOLOGIES INC (SIGA) | 10-K Mar 10, 2026 | “Pursuant to the current agreement with Grace, which was put in place in 2018 when Albemarle was the owner of the operations that provide services to SIGA, Grace manufactures, tests and supplies active pharmaceutical ingredient ("API") for use in TPOXX®.” |
| competitor | Elevra Lithium Ltd (ELVR) | 20-F Oct 31, 2025 | “Elevra competes against several major lithium producers, including: Albemarle Corporation, Sigma Lithium Corporation, Sociedad Química y Minera” |
ALB customer concentration
In the period ended Dec 31, 2023, a single direct customer accounted for 12% of revenue, per the company's 10-K filed Feb 11, 2026. The company does not name it.
ALB company outlook (results filed Aug 5, 2026)
- “Sales volumes are expected to be in the range of 225 to 235 kilotons lithium carbonate equivalent, as increased Wodgina volumes partially offset a delay in the Talison CGP3 ramp due to a fire that occurred on June 9.”
Quoted word-for-word from the SEC 8-K results press release.
ALB analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $2.52 | $3.44 | -26.6% | $1.52B | 16 |
| Next quarter (ends Dec 2026) | $1.92 | $3.25 | -40.8% | $1.41B | 15 |
| Current fiscal year (ends Dec 2026) | $11.29 | $12.59 | -10.3% | $6.07B | 20 |
| Next fiscal year (ends Dec 2027) | $10.80 | $12.52 | -13.7% | $6.17B | 19 |
Key Statistics (as of October 23, 2026 at 10:01 UTC)
| Price | USD 92.54 |
|---|---|
| Change | ▼ 2.04% (down) |
| Previous Close | USD 92.54 |
| Open | USD 92.54 |
| Day Range | USD 91 – 92.65 |
| 52-Week Range | USD 88.01 – 221 |
| Volume | 2,253,871 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (ALB)
Nexqual's technical model rates ALB "SELL" based on 2 bullish and 5 bearish signals across 127 daily candles, as of October 23, 2026 at 10:01 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 23.71 (oversold) |
| vs SMA50 | Below (USD 116.53) |
| MACD | -6.08 (negative) |
Earnings (ALB)
| Next Earnings Date | 2026-11-04 |
|---|---|
| EPS Estimate | USD 2.52 |
| Revenue Estimate | $1.52B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 3.75 vs est 3.24 ▲ beat |
| 2026-03-31 | USD 2.95 vs est 1.31 ▲ beat |
| 2025-12-31 | USD -0.53 vs est -0.49 ▼ miss |
| 2025-09-30 | USD -0.19 vs est -0.88 ▲ beat |
Source: Nexqual, October 23, 2026 at 10:01 UTC.
Financials & Fundamentals (ALB)
| Total Revenue | $5.91B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +31.10% |
| Gross Margin | +23.96% |
| Operating Margin | +27.71% |
| Profit Margin | +3.79% |
| ROE | +2.65% |
| Debt / Equity | 0.19 |
| Current Ratio | 2.09 |
| Total Cash | $1.63B |
| Total Debt | $2.00B |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | $1.34B (22.7% of revenue) |
Source: Nexqual, October 23, 2026 at 10:01 UTC.
Financial Health Score (ALB)
Nexqual rates Albemarle Corporation's overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 10:01 UTC.
| Growth | Weak — Revenue -4% YoY (annual), declining |
|---|---|
| Profitability | Mixed — Gross margin 24% (last 12 months) |
| Balance Sheet | Strong — $1.63B cash and investments vs $1.88B debt (Jun 2026, SEC) |
| Cash Flow | Strong — FCF $1.34B (last 4 quarters to Jun 2026, SEC), 23% margin |
| Efficiency | Weak — ROE 3%, ROA 3.2% |
Ownership (ALB)
| Insider Ownership | +0.21% |
|---|---|
| Institutional Ownership | +101.88% |
| Shares Outstanding | 118.01M |
| Float | 117.61M |
| Short % of Float | +11.37% |
Source: Nexqual, October 23, 2026 at 10:01 UTC.
From Albemarle Corporation's Latest SEC 10-K Filing (filed 2026-02-11)
Key Strengths & Strategy (as disclosed to the SEC)
- We believe that our world-class resources with reliable and consistent supply, our leading process chemistry, high-impact innovation, customer centricity and focus on people and planet will enable us to maintain a leading position in the industries in which we operate.
- As of December 31, 2025, we owned more than 1,500 active patents and more than 750 pending patent applications in key strategic markets worldwide.
Legal & Regulatory Risks (Item 1A, quoted)
- Regulation, or the threat of regulation, of some of our products could have an adverse effect on our sales and profitability.
- We could be subject to damages based on claims brought against us by our customers or lose customers as a result of the failure of our products to meet certain quality specifications.
- Our business could be adversely affected by environmental, health and safety laws and regulations.
- We may be subject to indemnity claims and liable for other payments relating to properties or businesses we have divested, including in connection with the divestiture of the controlling interest in our Refining Solutions business.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SSL | Sasol Ltd. | USD 17.46 | ▲ 7.84% |
| SOLS | Solstice Advanced Materials Inc | USD 59.8 | ▼ 7.99% |
| RPM | RPM International Inc. | USD 101.72 | ▲ 1.84% |
| WLK | Westlake Corporation | USD 64.14 | ▲ 5.42% |
| ESI | Element Solutions Inc. | USD 33.11 | ▼ 8.89% |
| NEU | NewMarket Corp | USD 876.33 | ▼ 0.98% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 10:01 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt